Nanoscale · 2024 · 13 citations · 43 references
MedicinePharmacologyToxicologyChemotherapyDrug DeliveryInflammationAnthracycline CardiotoxicityCardiac BiomarkersInflammation PharmacologyMechanisms Of Toxic InjuryNanomedicineNecrosisCardiotoxicityDoxorubicin CardiotoxicityHistopathological EvaluationLiposomal Delivery SystemsLiposomal NanocarriersMyofiber NecrosisTroponin ElevationTroponin Release
toxicity of PLGADOX was compared with clinically approved non-PEGylated, liposomal nanoformulation of DOX (LipoDOX) and conventional DOX form (ConvDOX). The study was performed using Wistar Han rats of both sexes that were treated intravenously for 28 days with 5 doses of tested substances at intervals of 5 days. Histopathological analyses of heart tissues showed the presence of myofiber necrosis, degeneration processes, myocytolysis, and hemorrhage after treatment with ConvDOX, whereas only myofiber degeneration and hemorrhage were present after the treatment with nanoformulations. All DOX formulations caused an increase in the troponin T with the greatest increase caused by convDOX. qPCR analyses revealed an increase in the expression of inflammatory markers IL-6 and IL-8 after ConvDOX and an increase in IL-8 expression after lipoDOX treatments. The mass spectra imaging (MSI) of heart tissue indicates numerous metabolic and lipidomic changes caused by ConvDOX, while less severe cardiac damages were found after treatment with nanoformulations. In the case of LipoDOX, autophagy and apoptosis were still detectable, whereas PLGADOX induced only detectable mitochondrial toxicity. Cardiotoxic effects were frequently sex-related with the greater risk of cardiotoxicity observed mostly in male rats.
43
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
K M Tewey, Thomas C. Rowe, Liu Yang et al. · Science · 1984 · 1.5K citations
Heloisa Sawaya, Igal A. Sebag, Juan Carlos Plana et al. · Circulation Cardiovascular Imaging · 2012 · 819 citations · Full text
Medicine, Oncology, Pharmacology +17
Gerald Batist, Gopal Ramakrishnan, Chandra Sekhar Rao et al. · Journal of Clinical Oncology · 2001 · 661 citations
Medicine, Oncology, Pharmacology +17